Plum SEC
Menu
Korean Market
Community
Contact Us
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
MATR
Aprogen Biologics
★★
Issuance of 10 Billion KRW 19th Convertible Bonds, Premium Conversion Price (4,433 KRW) via Third-Party Allotment to Largest Shareholder
10h ago
EXCH
Aprogen Biologics
★
Completion of 2 Billion Won Third-Party Allotment Capital Increase (592,593 Shares)
05/16/2026, 07:51 PM
EXCH
Aprogen Biologics
★★★
Major shareholder Aprogen increases stake to 58.73% via third-party allotment
05/16/2026, 07:51 PM
PERI
Aprogen Biologics
★★
Aprogen Biologics Reports Q1 2026 Operating Loss of KRW 13.6B, Implements Reverse Stock Split and Rights Offering
05/14/2026, 04:51 PM
OWNR
Aprogen Biologics
★
Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders
05/08/2026, 04:32 PM
OWNR
Aprogen Biologics
★★
Large Shareholding Report Filed for Management Influence - Stake Change Due to Capital Reduction
05/08/2026, 04:21 PM
OWNR
Aprogen Biologics
★
Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders
05/08/2026, 04:09 PM
OWNR
Aprogen Biologics
★
Executives/Major Shareholders Securities Ownership Report Filed (No Changes)
05/08/2026, 04:06 PM
OWNR
Aprogen Biologics
★
Executive/Major Shareholder Specific Securities Ownership Report Filed
05/08/2026, 04:05 PM
OWNR
Aprogen Biologics
★
Report on Ownership of Specific Securities by Executives/Major Shareholders (No Change)
05/08/2026, 04:02 PM
«
1
2
»